Figures & data
Table Ia. Patient and treatment characteristics (n = 248).
Table Ib. Clinical and sociodemographic characteristics (n = 248).
Table II. Mean values (95% CI) of the EORTC QLQ-C30 + QLQ-BR23 functional- and symptom scales at baseline and after RT.
Figure 2. Distribution of fatigue by surgery, chemotherapy, RT-technique, comorbidity, age and risk groups at baseline and after radiotherapy.
![Figure 2. Distribution of fatigue by surgery, chemotherapy, RT-technique, comorbidity, age and risk groups at baseline and after radiotherapy.](/cms/asset/4b5ca1e7-e022-4368-a4fe-94ce9786109c/ionc_a_604345_f0002_b.gif)
Table III. The prediction of change in fatigue during radiotherapy, adjusted for chemotherapy, comorbidity and age.